T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma

por Zhong, Sheng, Wu, Bo, Li, Jiahui, Wang, Xinhui, Jiang, Shanshan, Hu, Fangfei, Dou, Gaojing, Zhang, Yuan, Sheng, Chunjia, Zhao, Gang, Li, Yunqian, Chen, Yong
Publicado 2019

Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609

por Wu, Bo, Jiang, Shanshan, Wang, Xinhui, Zhong, Sheng, Bi, Yiming, Yi, Dazhuang, Liu, Ge, Hu, Fangfei, Dou, Gaojing, Chen, Yong, Wu, Yi, Dong, Jiajun
Publicado 2020